Company
IndiaPublic company, NYSE: RDYDr. Reddy's Laboratories Limited (NYSE: RDY), Nalgonda, India – FDA Inspections
Inspection records and compliance data for Dr. Reddy's Laboratories Limited in Nalgonda. 7 FDA inspections on record (1 OAI), 3 Form 483s, last inspected May 24, 2025. Publicly traded as NYSE: RDY.
Company Profile
This profile covers Dr. Reddy's Laboratories Limited based in Nalgonda, India.
FDA Inspection History
- FDA inspections
- 7
- OAI
- 1
- VAI
- 5
- NAI
- 0
- Unclassified
- 1
- Form 483s
- 3
- Warning letters
- 0
First inspected February 6, 2009. Last inspected May 24, 2025.
FDA inspections (7)
| Date | Result | FDA center(s) | Insp. # |
|---|---|---|---|
| May 24, 2025 | Not classified | Human Drugs | 1273868 |
| March 5, 2020 | VAI | Human Drugs · Drug Quality Assurance | 1121656 |
| January 28, 2019 | VAI | Human Drugs · Drug Quality Assurance | 1080643 |
| February 21, 2017 | VAI | Human Drugs · Drug Quality Assurance | 1005458 |
| January 31, 2015 | OAI | Human Drugs · Drug Quality Assurance | 921492 |
| May 1, 2012 | VAI | Human Drugs · Drug Quality Assurance | 780043 |
| February 6, 2009 | VAI | Human Drugs · Drug Quality Assurance | 568461 |
FDA documents
Other FDA documents (2)
Other regulators (1)
People (5)
Related Companies (10)
Companies with similar regulatory profiles, compliance history, and operations.
Company Information
Name
Dr. Reddy's Laboratories Limited
Stock ticker
RDY
Exchange
NYSE
Share price
$14.73
Market cap
$12.3B
Price as of
November 13, 2026
FEI Number
3005447965
Address
Peddadevulapally, Tripuraram Mandal, Nalgonda, India
Country
India
ID: 6e5a00e6-b2ca-4a53-9de3-c731fe0e8ab2